Skip to main content
Premium Trial:

Request an Annual Quote

Emma Millican, Harold Swerdlow

LGC has appointed Emma Millican as global NGS business unit manager and Harold Swerdlow as head of NGS technology development, positions the firm created to support the launch of its new NGS business unit. 

Millican was previously director of scientific operations at the Wellcome Trust Sanger Institute and prior to joining the Sanger Institute, she was the UK director of forensic and applied genetics at Eurofins.

Swerdlow joins LGC from the New York Genome Center, where he was vice president of sequencing. Previously, he was head of research and development at the Wellcome Trust Sanger Institute and also served as chief technology officer at the Dolomite Center.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.